These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 18357714)
1. [In vitro and in vivo studies on hydroxyapatite nanoparticles as a novel vector for inner ear gene therapy]. Sun H; Jiang M; Zhu SH Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Jan; 43(1):51-7. PubMed ID: 18357714 [TBL] [Abstract][Full Text] [Related]
2. Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: results of an in vitro and in vivo study. Zheng F; Shi XW; Yang GF; Gong LL; Yuan HY; Cui YJ; Wang Y; Du YM; Li Y Life Sci; 2007 Jan; 80(4):388-96. PubMed ID: 17074366 [TBL] [Abstract][Full Text] [Related]
3. Novel method for homogeneous gene transfer to the inner ear. Sugahara K; Shimogori H; Okuda T; Takemoto T; Yamashita H Acta Otolaryngol Suppl; 2004 Aug; (553):19-22. PubMed ID: 15277030 [TBL] [Abstract][Full Text] [Related]
4. Development of in vivo gene therapy for hearing disorders: introduction of adeno-associated virus into the cochlea of the guinea pig. Lalwani AK; Walsh BJ; Reilly PG; Muzyczka N; Mhatre AN Gene Ther; 1996 Jul; 3(7):588-92. PubMed ID: 8818645 [TBL] [Abstract][Full Text] [Related]
5. A regulated delivery system for inner ear drug application. Lajud SA; Han Z; Chi FL; Gu R; Nagda DA; Bezpalko O; Sanyal S; Bur A; Han Z; O'Malley BW; Li D J Control Release; 2013 Mar; 166(3):268-76. PubMed ID: 23313113 [TBL] [Abstract][Full Text] [Related]
6. [Hydroxyapatite nanoparticles: a novel material of gene carrier]. Zhu S; Zhou K; Huang B; Huang S; Liu F; Li Y; Xue Z; Long Z Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Oct; 22(5):980-4. PubMed ID: 16294735 [TBL] [Abstract][Full Text] [Related]
7. Gene transfer in inner ear cells: a challenging race. Sacheli R; Delacroix L; Vandenackerveken P; Nguyen L; Malgrange B Gene Ther; 2013 Mar; 20(3):237-47. PubMed ID: 22739386 [TBL] [Abstract][Full Text] [Related]
8. [Feasibility of inner ear gene transfer after middle ear administration of an adenovirus vector]. Stöver T; Kawamoto K; Kanzaki S; Raphael Y Laryngorhinootologie; 2001 Aug; 80(8):431-5. PubMed ID: 11552421 [TBL] [Abstract][Full Text] [Related]
9. Development of a drug delivery system for the inner ear using poly(amino acid)-based nanoparticles. Kim DK; Park SN; Park KH; Park CW; Yang KJ; Kim JD; Kim MS Drug Deliv; 2015 May; 22(3):367-74. PubMed ID: 24447111 [TBL] [Abstract][Full Text] [Related]
10. Intratympanic delivery of oligoarginine-conjugated nanoparticles as a gene (or drug) carrier to the inner ear. Yoon JY; Yang KJ; Kim DE; Lee KY; Park SN; Kim DK; Kim JD Biomaterials; 2015 Dec; 73():243-53. PubMed ID: 26414408 [TBL] [Abstract][Full Text] [Related]
11. A novel inner ear monitoring system for evaluating ototoxicity of gentamicin eardrops in guinea pigs. Yang TH; Liu SH; Young YH Laryngoscope; 2010 Jun; 120(6):1220-6. PubMed ID: 20513043 [TBL] [Abstract][Full Text] [Related]
12. [Research on the acute audio-toxicity of aspirin in the guinea pig]. Crifò S; Sidoli A; Difeliciantonio D; Di Francesco G; Falò S Boll Soc Ital Biol Sper; 1974 Feb; 50(3):99-103. PubMed ID: 4425599 [No Abstract] [Full Text] [Related]
13. [Biological effects of laser beams in otolaryngology. Medical application approach]. Belkahia A Ann Otolaryngol Chir Cervicofac; 1971 Sep; 88(9):467-73. PubMed ID: 5122192 [No Abstract] [Full Text] [Related]
14. Ototoxicity of loop diuretics. Morphological and electrophysiological examinations in animal experiments. Hommerich CP Adv Otorhinolaryngol; 1990; 44():92-164. PubMed ID: 2407070 [No Abstract] [Full Text] [Related]
15. [Protective effect of NT-3 gene mediated by hydroxyapatite nanoparticle on the cochlea of guinea pigs injured by excitotoxicity]. Jiang M; Zhang YQ; He GX; Sun H Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):563-7. PubMed ID: 17767042 [TBL] [Abstract][Full Text] [Related]
16. The influence of ischemia upon the energy reserves of inner ear tissues. Thalmann R; Miyoshi T; Thalmann I Laryngoscope; 1972 Dec; 82(12):2249-72. PubMed ID: 4539701 [No Abstract] [Full Text] [Related]
17. Cell-gene delivery of brain-derived neurotrophic factor to the mouse inner ear. Okano T; Nakagawa T; Kita T; Endo T; Ito J Mol Ther; 2006 Dec; 14(6):866-71. PubMed ID: 16956795 [TBL] [Abstract][Full Text] [Related]
18. Pharmacologic treatment of inner ear: from basic science to the patient. Lefebvre PP; Staecker H; Van de Water T; Moonen G; Malgrange B Acta Otorhinolaryngol Belg; 2002; 56(1):45-9. PubMed ID: 11894630 [TBL] [Abstract][Full Text] [Related]
19. Nanoparticle-based delivery for the treatment of inner ear disorders. Pyykkö I; Zou J; Zhang W; Zhang Y Curr Opin Otolaryngol Head Neck Surg; 2011 Oct; 19(5):388-96. PubMed ID: 21897248 [TBL] [Abstract][Full Text] [Related]
20. [In vitro dexamethasone release from nanoparticles and its pharmacokinetics in the inner ear after administration of the drug-loaded nanoparticles via the round window]. Chen G; Hou SX; Hu P; Hu QH; Guo DD; Xiao Y Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1022-4. PubMed ID: 18583254 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]